Gabapentin: A review of published experience in the treatment of bipolar disorder and other psychiatric conditions

Pharmacotherapy

Volumn 19, Issue 5, 1999, Pages 565-572

  Letterman, Laura ^a   Markowitz, John S ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ADULT; ANTICONVULSANT ACTIVITY; ANXIETY NEUROSIS; BEHAVIOR DISORDER; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; SEDATION; SHORT SURVEY; SUBSTANCE ABUSE; VERTIGO;

ACETIC ACIDS; AMINES; ANTICONVULSANTS; ANXIETY; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 0032924513     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.8.565.31521     Document Type: Short Survey

References (32)

1. Freeman MP, Stell AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155(1):12-21.
2. Bowden CL. Role of newer medications for bipolar disorder. J Clin Psychopharmacol 1996;16(2;suppl 1):48s-55.
3. Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998;19:206-19.
4. Post RM, Weiss SRB, Chuang D. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol 1992;12(suppl):23s-35.
5. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782-90.
6. McLean MJ. Gabapentin. Epilepsia 1995;36(suppl. 2):s73-86.
7. Taylor CP. Mechanism of action of gabapentin. Drugs of Today 1998;34:3-11.
8. Parke Davis. Neurontin (gabapentin) package insert. Morris Plains, NJ;1998 Feb.
9. Bruni J. Gabapentin. Can J Neurol Sci 1996;23(suppl):S10-12.
10. Stanton SP, Keck PE, McElroy SL. Treatment of acute mania with gabapentin. Am J Psychiatry 1997;154(2):287.
11. Bennett J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997;17(2):141-2.
12. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997;154(2):291-2.
13. Schaffer CB, Schaffer LC. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. J Affect Disord In press.
14. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci 1997;9:301.
15. McElroy SL, Soutullo CA, Keck PE, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997;9(2):99-103.
16. Young LT, Robb JC, Patelis-Siotis I, et al. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997;42:851-3.
17. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998;49:229-33.
18. Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 1998;59(8):426-9.
19. Erfurth A, Kammerer C, Grunze H, Norman C, Walden J. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 1998;32:261-4.
20. Chouinard G, Geauclair L, Belanger MC. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can J Psychiatry 1998;43(3):305.
21. Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry 1998;155(7):992-1.
22. Cora-Locatelli G, Greenberg BD, Martin JD, Murphy DL. Rebound psychiatric and physical symptoms after gabapentin discontinuation. J Clin Psychiatry 1998;59(3):131.
23. Markowitz JS, Finkenbine R, Myrick H, King L, Carson WH. Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol 1997;17(5):423-4.
24. Myrick H, Malcolm R, Brady KT. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 1998;155:1632.
25. Peris J. Repeated cocaine injections decrease the function of striatal gamma-aminobutyric acid (A) receptors. J Pharmacol Exp Ther 1996;276:1002-8.
26. Sheldon LJ, Ancill RJ, Holliday SG. Gabapentin in geriatric psychiatry patients. Can J Psychiatry 1998;43(4):422-3.
27. Goldenberg G, Kahaner K, Basavaraju N, Rangu S. Gabapentin for disruptive behaviour in an elderly demented patient. Drugs Aging 1998;13(2):183-4.
28. Ryback R, Ryback L. Gabapentin for behavioral dyscontrol. Am J Psychiatry 1995;152(9):1399.
29. Soutullo CA, Casuto LS, Keck PE. Gabapentin in the treatment of adolescent mania: a case report. J Child Adolesc Psychopharmacol 1998;8(1):81-5.
30. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996;37(5):501-2.
31. Wolf SM, Shinnar S, Kang H, Gil KB, Moshe SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1996;36(12):1203-5.
32. Short C, Cooke L. Hypomania induced by gabapentin. Br J Psychiatry 1995;166:679-80.